As access to mainland-listed ‘A shares’ expands, there are questions about tax on gains from 2009 through last year.
HSBC is again considering moving its headquarters outside the U.K. because of the costs imposed by regulation. It can’t get away that easily.
GlaxoSmithKline’s malaria vaccine, the world’s most advanced, loses effectiveness over time, even with a booster shot, according to new clinical-trial results.
American companies continue to curtail spending on big-ticket products such as equipment and machinery, the latest sign the U.S. economy got clobbered in the first quarter by troubles at home and abroad.
The author of “The Sculptor” on the utility of laptop tents, old iPads and travel mugs.
Box’s founders paid a steep price for venture capital the cloud-software firm got on the way to an IPO.
U.K. pharmaceutical company AstraZeneca is doing deals to help bolster near-term revenues, potentially at the cost of future earnings.
Talks in Riga brought no joy on Greece. Markets face persistent uncertainty as a result.
Chevron Phillips Chemical is one of many companies around the country pushing programs to help close a skills gap that is weighing on the middle class and entrenching a growing income inequality.
The Brazilian oil major’s mammoth write off doesn’t address bigger challenges around its debt burden.